BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$3.53B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1 +$122M
2 +$76M
3 +$74.4M
4
ALKS icon
Alkermes
ALKS
+$50.4M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$37.1M

Top Sells

1 +$145M
2 +$26.7M
3 +$21.2M
4
VERV
Verve Therapeutics
VERV
+$19M
5
BPMC
Blueprint Medicines
BPMC
+$16.1M

Sector Composition

1 Healthcare 99.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$37.7B
$3B 21.66%
8,799,053
INCY icon
2
Incyte
INCY
$20.5B
$2.61B 18.84%
30,743,663
+388
MDGL icon
3
Madrigal Pharmaceuticals
MDGL
$13.6B
$982M 7.1%
2,141,701
+165,683
INSM icon
4
Insmed
INSM
$44.3B
$965M 6.98%
6,703,484
-1,009,416
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.24B
$915M 6.61%
42,896,690
SMMT icon
6
Summit Therapeutics
SMMT
$13.3B
$697M 5.03%
33,722,974
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$7.28B
$566M 4.09%
5,604,483
RVMD icon
8
Revolution Medicines
RVMD
$15B
$442M 3.19%
9,455,357
+90,385
CELC icon
9
Celcuity
CELC
$4.68B
$391M 2.83%
7,915,792
+2,465,347
KYMR icon
10
Kymera Therapeutics
KYMR
$4.88B
$376M 2.72%
6,651,429
KOD icon
11
Kodiak Sciences
KOD
$1.22B
$283M 2.05%
17,310,490
ALKS icon
12
Alkermes
ALKS
$4.88B
$243M 1.75%
8,091,351
+1,680,748
ABCL icon
13
AbCellera Biologics
ABCL
$1.12B
$138M 1%
27,525,640
EWTX icon
14
Edgewise Therapeutics
EWTX
$2.76B
$119M 0.86%
7,305,940
KNSA icon
15
Kiniksa Pharmaceuticals
KNSA
$3.22B
$110M 0.79%
2,824,669
STOK icon
16
Stoke Therapeutics
STOK
$1.77B
$109M 0.79%
4,633,838
IMTX icon
17
Immatics
IMTX
$1.3B
$103M 0.74%
12,094,094
+1,925,193
GRAL
18
GRAIL Inc
GRAL
$4.3B
$96.4M 0.7%
1,630,125
IDYA icon
19
IDEAYA Biosciences
IDYA
$3.12B
$89.1M 0.64%
3,275,444
+1,156,716
IMVT icon
20
Immunovant
IMVT
$4.23B
$88M 0.64%
5,457,881
IMCR icon
21
Immunocore
IMCR
$2B
$84.4M 0.61%
2,322,656
BCYC
22
Bicycle Therapeutics
BCYC
$519M
$84.3M 0.61%
10,885,357
RARE icon
23
Ultragenyx Pharmaceutical
RARE
$3.35B
$83.4M 0.6%
2,772,692
ABVX
24
Abivax
ABVX
$9.72B
$74.4M 0.54%
+875,796
ARWR icon
25
Arrowhead Research
ARWR
$7.16B
$57.6M 0.42%
1,670,762
+731,588